Start-Up Quarterly Statistics, Q1 2012

In the first quarter of 2012, biopharma start-ups raised $338.1 million – 51% less than the previous quarter but a 62% hike from Q1 2011. Series B rounds dominated, generating 43% of the total. Medical device companies brought in $123.7 million – down 11% from Q4 2011 – and 46% of the money was from two Series C financings. In vitro diagnostics start-ups raised a total of $99.3 million, of which 71% or $71 million resulted from three companies’ Series C rounds. (See Exhibit 1.)